E. V. Tsareva
Research Subjects
Research Interests
E. V. Tsareva has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Olga V. Kotova
Peoples' Friendship University of Russia
2 shared publications - A.A. Belyaev
Sklifosovsky Scientific Research Institute of Emergency Medical Care, Moscow, Russia
1 shared publication - Dmitry Vladislavovich Blinov
Federal Scientific and Clinical Center for Medical Rehabilitation and Balneology of the Federal Medical and Biological Agency; Institute for Preventive and Social Medicine; Moscow Haass Medical Social Institute
1 shared publication - E.V. Gushanskaya
RUDN University, Department of Psychiatry, Psychotherapy and Psychosomatic Pathology, Moscow
1 shared publication - Elena S. Akarachkova
International Society “Stress under control
1 shared publication - I.G. Kotelnikova
Moscow Endocrine Plant
1 shared publication
Latest Publications
- Open Access
- 27 July 2023
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 12,p. 210-220
Stress and stress-associated disorders in children
Stress in childhood affects not only the current health status of children, but also their psychosocial and somatic functioning at a more mature age, which leads to grave consequences in the long term, as well as higher frequencies of use of healthcare financial resources. The ability of a physician to identify clinical manifestations of stress in children with somatic diseases or during dispensary examination, on the one hand, is important for prescribing adequate therapy, helps determine a preventive approach to the management of children with stress-related consequences, and also to form a relevant set of actions to increase their stress resistance and create an adequate adaptive reserve and reactions at all levels of the body. On the other hand, it is important to identify children under chronic stress (the so-called point of no return), who have a high risk of developing psychosomatic diseases. The article also discusses the basics of a healthy lifestyle for children that makes it possible to not only increase adaptive capabilities, but also essentially mitigate the effects of chronic stress. For example, it addresses recommendations such as complete and proper nutrition, regular physical activity combined with rest, coping skills training. However, the authors emphasize that the most difficult part of all recommendations is their direct fulfilment by children themselves and by their environment (parents, teachers). Therefore, the issues of compliance with the prescribed therapy and preventive actions become very important, especially in situations where their fulfilment is associated with subjective and objective difficulties. The authors tried to suggest some ways of overcoming the latter.
- 27 July 2023
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 12,p. 210-220
Open AccessStress and stress-associated disorders in children
Stress in childhood affects not only the current health status of children, but also their psychosocial and somatic functioning at a more mature age, which leads to grave consequences in the long term, as well as higher frequencies of use of healthcare financial resources. The ability of a physician to identify clinical manifestations of stress in children with somatic diseases or during dispensary examination, on the one hand, is important for prescribing adequate therapy, helps determine a preventive approach to the management of children with stress-related consequences, and also to form a relevant set of actions to increase their stress resistance and create an adequate adaptive reserve and reactions at all levels of the body. On the other hand, it is important to identify children under chronic stress (the so-called point of no return), who have a high risk of developing psychosomatic diseases. The article also discusses the basics of a healthy lifestyle for children that makes it possible to not only increase adaptive capabilities, but also essentially mitigate the effects of chronic stress. For example, it addresses recommendations such as complete and proper nutrition, regular physical activity combined with rest, coping skills training. However, the authors emphasize that the most difficult part of all recommendations is their direct fulfilment by children themselves and by their environment (parents, teachers). Therefore, the issues of compliance with the prescribed therapy and preventive actions become very important, especially in situations where their fulfilment is associated with subjective and objective difficulties. The authors tried to suggest some ways of overcoming the latter.
- 1 January 2022
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 122 (12) , 39-44
Clinical aspects of the use of imidazopyridine derivatives in the treatment of sleep disorders associated with post-COVID syndrome
В 2019 г. началась пандемия, вызванная вирусом SARS-CoV-2. Борьба с COVID-19 потребовала введения ряда ограничительных мер, в частности карантина для населения и изоляции заболевших, что наряду с непосредственным влиянием вируса на нервную систему привело к значительному распространению нарушений сна. В связи с этим стали актуальными вопросы о выборе препаратов для коррекции нарушений сна, о том, какие снотворные препараты будут безопасны в условиях острого заболевания и в период восстановления после COVID-19. В статье обсуждаются проблемы распространенности и терапии инсомнии у пациентов с острым COVID-19 и с постковидным синдромом (ПКС). Описываются фармакологические эффекты и безопасность золпидема — небензодиазепинового снотворного препарата короткого действия, относящегося к классу имидазопиридинов, который применяют короткими курсами при инсомнии как острой и транзиторной, так и хронической. Приводятся данные о способности золпидема улучшать память после ночного сна. Оценивается возможность его применения при остром COVID-19 и ПКС.
- 1 January 2022
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 122 (12) , 39-44
Clinical aspects of the use of imidazopyridine derivatives in the treatment of sleep disorders associated with post-COVID syndrome
В 2019 г. началась пандемия, вызванная вирусом SARS-CoV-2. Борьба с COVID-19 потребовала введения ряда ограничительных мер, в частности карантина для населения и изоляции заболевших, что наряду с непосредственным влиянием вируса на нервную систему привело к значительному распространению нарушений сна. В связи с этим стали актуальными вопросы о выборе препаратов для коррекции нарушений сна, о том, какие снотворные препараты будут безопасны в условиях острого заболевания и в период восстановления после COVID-19. В статье обсуждаются проблемы распространенности и терапии инсомнии у пациентов с острым COVID-19 и с постковидным синдромом (ПКС). Описываются фармакологические эффекты и безопасность золпидема — небензодиазепинового снотворного препарата короткого действия, относящегося к классу имидазопиридинов, который применяют короткими курсами при инсомнии как острой и транзиторной, так и хронической. Приводятся данные о способности золпидема улучшать память после ночного сна. Оценивается возможность его применения при остром COVID-19 и ПКС.